Cancer Registration Data Set

Cancer Registration Data Set Overview

Please note that the Cancer Registration Data Set will be replaced by the Cancer Outcomes and Services Data Set which is planned to be mandated from 1 January 2013. For further details, see the National Cancer Intelligence Network (NCIN) website.

Data Set Data Elements 
DEMOGRAPHICS:
It is anticipated that some of the demographic data items listed below will be collected by every provider with which the patient has contact.
Where this information is exchanged, the appropriate data item name should be used to identify the particular instance of the data.
Notes:
NHS NUMBER  
LOCAL PATIENT IDENTIFIER  
ORGANISATION CODE (CODE OF PROVIDER)  
CARE SPELL IDENTIFIER  
PERSON FAMILY NAME  
PERSON GIVEN NAME  
PATIENT USUAL ADDRESS (AT DIAGNOSIS)  
POSTCODE OF USUAL ADDRESS (AT DIAGNOSIS)  
PERSON GENDER CURRENT  
PERSON BIRTH DATE  
GENERAL MEDICAL PRACTITIONER (SPECIFIED) This need only be collected by those sites who find it difficult to collect the GP Practice Code below.
GENERAL MEDICAL PRACTICE CODE (PATIENT REGISTRATION)  
ORGANISATION CODE (RESPONSIBLE PCT) This need not be collected directly by clinical staff
PERSON FAMILY NAME (AT BIRTH) This is not usually readily available from a hospital PAS system. It should be collected prospectively on contact with the patient.
ETHNIC CATEGORY  
REFERRALS 
REFERRING ORGANISATION CODE  
REFERRER CODE  
CANCER REFERRAL PRIORITY TYPE  
CANCER REFERRAL DECISION DATE  
REFERRAL REQUEST RECEIVED DATE  
CONSULTANT CODE Referred to
MAIN SPECIALTY CODE Can be derived from consultant code
DATE FIRST SEEN  
DELAY REASON REFERRAL TO FIRST SEEN (CANCER OR BREAST SYMPTOMS)  
DELAY REASON COMMENT (FIRST SEEN)  
TWO WEEK WAIT CANCER OR SYMPTOMATIC BREAST REFERRAL TYPE  
CANCER OR SYMPTOMATIC BREAST REFERRAL PATIENT STATUS  
WAITING TIME ADJUSTMENT (FIRST SEEN)  
WAITING TIME ADJUSTMENT REASON (FIRST SEEN)  
SOURCE OF REFERRAL FOR OUT-PATIENTS  
SITE CODE (OF IMAGING)  
CLINICAL INTERVENTION DATE (CANCER IMAGING)  
CANCER IMAGING MODALITY  
ANATOMICAL EXAMINATION SITE  
INVASIVE LESION SIZE (RADIOLOGICAL DETERMINATION)  
DIAGNOSIS:
These fields should record the definitive diagnosis as known to the hospital in question, based on the information available at the time the items were completed. There will be only one definitive diagnosis entry held.
 
DIAGNOSIS DATE (CANCER)  
PRIMARY DIAGNOSIS (ICD)  
TUMOUR LATERALITY  
BASIS OF DIAGNOSIS (CANCER)  
HISTOLOGY (SNOMED)  
GRADE OF DIFFERENTIATION (AT DIAGNOSIS)  
CANCER CARE PLAN:
There may be a number of cancer care plans, on different dates.
 
MULTIDISCIPLINARY TEAM DISCUSSION INDICATOR Was this cancer care plan discussed at an MDT meeting?
MULTIDISCIPLINARY TEAM DISCUSSION DATE (CANCER) The date of the MDT meeting at which the cancer care plan was discussed
CARE PLAN AGREED DATE  
RECURRENCE INDICATOR  
CANCER CARE PLAN INTENT  
PLANNED CANCER TREATMENT TYPE  
TREATMENT TYPE SEQUENCE  
NO CANCER TREATMENT REASON  
CO-MORBIDITY INDEX FOR ADULTSInvestigations into the possible use of the ACE-27 coding system are continuing.
PERFORMANCE STATUS (ADULT)  
STAGING:
These fields should be recorded at the time that the first cancer care plan is agreed. Cancer registries require the first pre-treatment stage, i.e. the stage at diagnosis.
 
T CATEGORY (FINAL PRETREATMENT)  
STAGING CERTAINTY FACTOR (T CATEGORY)  
N CATEGORY (FINAL PRETREATMENT)  
STAGING CERTAINTY FACTOR (N CATEGORY)  
M CATEGORY (FINAL PRETREATMENT)  
STAGING CERTAINTY FACTOR (M CATEGORY)  
TNM CATEGORY (FINAL PRETREATMENT)  
STAGING CERTAINTY FACTOR (TNM CATEGORY)  
SITE SPECIFIC STAGING CLASSIFICATION  
TNM CATEGORY (INTEGRATED)  
T CATEGORY (INTEGRATED STAGE)  
N CATEGORY (INTEGRATED STAGE)  
M CATEGORY (INTEGRATED STAGE)  
SURGERY AND OTHER PROCEDURES:
This can be adapted for other procedures including interventional radiology, laser treatment, endoscopies etc. and photo-dynamic procedures. This also includes procedures offered as supportive care.
 
SITE CODE (OF SURGERY)  
CONSULTANT CODE Managing consultant code
MAIN SPECIALTY CODE Can be derived from consultant code
CANCER TREATMENT INTENT  
DECISION TO TREAT DATE (SURGERY)  
START DATE (SURGERY HOSPITAL PROVIDER SPELL)  
PROCEDURE DATE  
PRIMARY PROCEDURE (OPCS)  
PROCEDURE (OPCS) This may occur more than once
DISCHARGE DATE (HOSPITAL PROVIDER SPELL)  
DISCHARGE DESTINATION (HOSPITAL PROVIDER SPELL)  
PATHOLOGY DETAILS:
It is expected that all the data items on the minimum RCPath data set will be collected. The pathology data items below are a subset of that data set. A patient may have any number of pathology reports, and there may be more than one pathology report per specimen. If the original report is reviewed or revised, then a new pathology module will need to be completed and dated, with the data item 'Second Opinion' on the RCPath data set marked as 'Y'
 
PATHOLOGY INVESTIGATION TYPE  
SAMPLE RECEIPT DATE  
INVESTIGATION RESULT DATE  
CONSULTANT CODE (PATHOLOGIST)  
ORGANISATION CODE (OF REPORTING PATHOLOGY)  
PRIMARY DIAGNOSIS (ICD)  
TUMOUR LATERALITY  
INVASIVE LESION SIZE  
SYNCHRONOUS TUMOUR INDICATOR  
HISTOLOGY (SNOMED)  
GRADE OF DIFFERENTIATION  
CANCER VASCULAR OR LYMPHATIC INVASION  
EXCISION MARGIN  
NODES EXAMINED NUMBER  
NODES POSITIVE NUMBER  
T CATEGORY (PATHOLOGICAL)  
N CATEGORY (PATHOLOGICAL)  
M CATEGORY (PATHOLOGICAL)  
TNM CATEGORY (PATHOLOGICAL)  
SERVICE REPORT IDENTIFIER  
SERVICE REPORT STATUS  
SPECIMEN NATURE  
ORGANISATION CODE (REQUESTED BY)  
CARE PROFESSIONAL CODE (REQUESTED BY)  
T CATEGORY EXTENDED (PATHOLOGICAL)  
M CATEGORY EXTENDED (PATHOLOGICAL)  
CHEMOTHERAPY AND OTHER DRUGS:
Chemotherapy and/or other anti-Cancer and/or Supportive drugs given to the patient during their treatment.
 
SITE CODE (OF CANCER DRUG TREATMENT)  
CONSULTANT CODE Managing Consultant
MAIN SPECIALTY CODE Can be derived from consultant code
DECISION TO TREAT DATE (ANTI-CANCER DRUG REGIMEN)  
DRUG THERAPY TYPE  
DRUG TREATMENT INTENT  
DRUG REGIMEN ACRONYM  
START DATE (ANTI-CANCER DRUG REGIMEN)  
RADIOTHERAPY 
Radiotherapy (Teletherapy):
A course of teletherapy is defined as a string of prescriptions which are consecutive.
 
SITE CODE (OF TELETHERAPY)  
CONSULTANT CODE Managing consultant
DECISION TO TREAT DATE (TELETHERAPY TREATMENT COURSE)  
CANCER TREATMENT INTENT  
ANATOMICAL EXAMINATION SITE  
START DATE (TELETHERAPY TREATMENT COURSE)  
Radiotherapy (Brachytherapy):
A course of brachytherapy is defined as a string of prescriptions which are consecutive.
 
SITE CODE (OF BRACHYTHERAPY)  
CONSULTANT CODE Managing Consultant
DECISION TO TREAT DATE (BRACHYTHERAPY TREATMENT COURSE)  
CANCER TREATMENT INTENT  
BRACHYTHERAPY TYPE  
ANATOMICAL EXAMINATION SITE  
START DATE (BRACHYTHERAPY TREATMENT COURSE)  
PALLIATIVE CARE:
It is expected that this section will be completed whenever an intervention occurs that involves one face-to-face contact with the patient. It is expected that a Cancer Care Plan will also be completed for the Palliative Care Management Plan.
The Palliative Care data items are in the process of being developed.
DECISION TO TREAT DATE (SPECIALIST PALLIATIVE TREATMENT COURSE)  
START DATE (SPECIALIST PALLIATIVE TREATMENT COURSE)  
CLINICAL TRIALS:
Additional information corresponding to patients ineligible for a trial, or whether there is no trial available, can be recorded if required.
Clinical Trials information will be completed for every Clinical Trial in which the patient is involved
PATIENT TRIAL STATUS (CANCER)  
CANCER CLINICAL TRIAL TREATMENT TYPE  
DEATH DETAILS 
PERSON DEATH DATE  
DEATH LOCATION TYPE  
DEATH CAUSE IDENTIFICATION METHOD  
The data items below will usually not be collected directly by the Trust; information would come from Cancer Registries. 
DEATH CAUSE CODE (IMMEDIATE)  
DEATH CAUSE CODE (CONDITION)  
DEATH CAUSE CODE (UNDERLYING)  
DEATH CAUSE CODE (SIGNIFICANT)